Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230020/S011

Altius Direct Electrical Nerve Stimulation System

Neuros Medical, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP230020/S011

What did the FDA decide?

The FDA record P230020/S011 shows a 30-day notice, decision OK30 dated 2026-10-16, for the Altius® Direct Electrical Nerve Stimulation System from Neuros Medical, Inc. The stated change is outsourcing insulator die-cutting activities and updating the associated dimensional tolerances. The supplement reason is filed as a process change affecting manufacturer, sterilizer, packager or supplier. This is a manufacturing supplement to PMA P230020, not a new approval of the whole system.

The supplied statement does not specify which die-cutting steps move to which supplier, what tolerance values changed, or what verification the applicant submitted. Its reported purpose is a process change; the notice itself does not demonstrate safety or clinical effectiveness, and no new indication or trial is implied. The device category field covers a totally implanted nerve terminus stimulator for chronic intractable post-amputation pain of the lower limb, product code SAZ.

FDA approval order statement

outsourcing insulator die-cutting activities and updating the associated dimensional tolerances
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P230020/S011
Regulatory pathway
PMA supplement
Product code
SAZ
Decision code
OK30
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb.

Product code
SAZ
FDA device class
3

For the original device and its historical approval scope, see PMA P230020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P230020 · Original PMA

    Altius Direct Electrical Nerve Stimulation System

  2. P230020/S011 received

    Application receipt date recorded by FDA.

  3. P230020/S011 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P230020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230020

Product / regulatory recordCompanyPathwayDecision dateSource
Neuros Medical, Inc.PMA approvalAug 26, 2024FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Neuros Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records